M. Rask-Andersen
Molecular Biology · 2011–2017
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 21 citations into it
- Computational Theory and Mathematics — 13 citations into it
Whom M. Rask-Andersen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from M. Rask-Andersen's perspective
Ordered by how strongly the researchers M. Rask-Andersen trusts endorse each paper. Same corpus, a different order for every researcher.
- Drug discovery: a historical perspective. (Science)
- The druggable genome (Nature reviews. Drug discovery)
- Network pharmacology: the next paradigm in drug discovery. (Nature Chemical Biology)
- DrugBank: a knowledgebase for drugs, drug actions and drug targets
- The Protein Data Bank.
- ChEMBL: a large-scale bioactivity database for drug discovery
- Metabolite profiling for plant functional genomics (Nature Biotechnology)
- A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations (Nature Biotechnology)
- Systematic functional analysis of the Caenorhabditis elegans genome using RNAi (Nature)
- Drugs, their targets and the nature and number of drug targets (Nature reviews. Drug discovery)
Their papers
- Trends in the exploitation of novel drug targets (2011) — 830 citations
- Trends in GPCR drug discovery: new agents, targets and indications (2017) — 2,288 citations